Home › Malignant Fibrous Histiocytoma › New York › New York City
Malignant Fibrous Histiocytoma clinical trials in New York City, NY
3 studies for Malignant Fibrous Histiocytoma are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
RecruitingPhase 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
Malignant Fibrous Histiocytoma trials in other cities
Other studies in New York City
- Breast Cancer144 studies
- Non-Small Cell Lung Cancer123 studies
- Cancer (all types)105 studies
- Prostate Cancer101 studies
- Metastatic Cancer93 studies
- Colorectal Cancer86 studies
- Ovarian Cancer75 studies
- Lung Cancer60 studies
- Multiple Myeloma59 studies
- Pancreatic Cancer57 studies
- Endometrial Cancer54 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.